UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
Commission File Number: 333-171658
 
 
(Check One):
x  Form 10-K       o Form 11-K       o Form 20-F        o Form 10-Q      o Form N-SAR      o Form N-CSR
   
 
For Year Ended: June 30, 2013
 
 
o
Transition Report on Form 10-K
 
o
Transition Report on Form 20-F
 
o
Transition Report on Form 11-K
 
o
Transition Report on Form 10-Q
 
o
Transition Report on Form N-SAR
     
  For the Transition Period Ended:
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information Contained herein.
 
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
 
 
PART I - REGISTRANT INFORMATION

Nano Labs Corp.
Full Name of Registrant
 
 
Former Name if Applicable
 
The Ford Building
615 Griswold Street, 17th Floor
Suite 1715
Address of Principal Executive Office (Street and Number)
 
Detroit, MI  48226
City, State and Zip Code
 
 
 
1
 
 
 
PART II - RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
 
x
(a)
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

x
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR or Form N-CSR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
o
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
PART III - NARRATIVE
 
State below in reasonable detail why the Form 10-K, 11-K, 20-F, 10-Q, N-SAR, N-CSR or the transition report or portion thereof could not be filed within the prescribed time period. (Attach extra Sheets if Needed.)
 
The Registrant is unable to file its Annual Report on Form 10-K for the year ended June 30, 2013 (the “Form 10-K”) within the prescribed time period because it requires additional time for the review and completion of its financial statements. The Registrant represents that the Form 10-K will be filed within the period described under Rule 12b-25(b)(ii).

 
PART IV - OTHER INFORMATION
 
(1)
Name and telephone number of person to contact in regard to this notification
           
 
Bernardo Camacho Chararria
 
888
 
806-2315
 
(Name)
 
(Area Code)
 
(Telephone Number)
           
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

 
  x Yes     o   No
   
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
   
 
  o Yes     x No
   
 
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 

 
 
2
 
 
 
Nano Labs Corp.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 

Date:
         September 30, 2013
 
By:
/s/ Bernardo Camacho Chararria
 
       
Name:   Bernardo Camacho Chararria
 
        Title:     President/Chief Executive Officer  
 
 
 

 
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
 
ATTENTION
Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001
 
 
 
 
 
 
 
 
 
 
 
 
 
 

3